WallStSmart

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsNebius Group N.V. (NBIS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nebius Group N.V. generates 1141% more annual revenue ($529.80M vs $42.68M). NBIS leads profitability with a 19.2% profit margin vs -6.5%. HAO trades at a lower P/E of 0.4x. NBIS earns a higher WallStSmart Score of 47/100 (D+).

HAO

Hold

39

out of 100

Grade: F

Growth: 8.7Profit: 2.0Value: 6.3Quality: 5.0

NBIS

Hold

47

out of 100

Grade: D+

Growth: 8.0Profit: 4.0Value: 6.0Quality: 5.5
Piotroski: 5/9Altman Z: 0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HAOFair Value (-1.6%)

Margin of Safety

-1.6%

Fair Value

$1.22

Current Price

$0.72

$0.49 premium

UndervaluedFair: $1.22Overvalued
NBISUndervalued (+15.4%)

Margin of Safety

+15.4%

Fair Value

$188.18

Current Price

$141.19

$46.99 discount

UndervaluedFair: $188.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO4 strengths · Avg: 10.0/10
P/E RatioValuation
0.4x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

EPS GrowthGrowth
172.7%10/10

Earnings expanding 172.7% YoY

NBIS2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
501.0%10/10

Revenue surging 501.0% year-over-year

PEG RatioValuation
0.638/10

Growing faster than its price suggests

Areas to Watch

HAO4 concerns · Avg: 2.0/10
Market CapQuality
$65.98M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-16.0%2/10

ROE of -16.0% — below average capital efficiency

Free Cash FlowQuality
$-2.27M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-6.5%1/10

Currently unprofitable

NBIS4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.7%3/10

ROE of 0.7% — below average capital efficiency

Debt/EquityHealth
1.063/10

Elevated debt levels

P/E RatioValuation
1283.5x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : NBIS

The strongest argument for NBIS centers on Revenue Growth, PEG Ratio. Profitability is solid with margins at 19.2% and operating margin at -103.0%. Revenue growth of 501.0% demonstrates continued momentum.

Bear Case : HAO

The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : NBIS

The primary concerns for NBIS are EPS Growth, Return on Equity, Debt/Equity. A P/E of 1283.5x leaves little room for execution misses.

Key Dynamics to Monitor

HAO profiles as a hypergrowth stock while NBIS is a growth play — different risk/reward profiles.

NBIS carries more volatility with a beta of 1.06 — expect wider price swings.

NBIS is growing revenue faster at 501.0% — sustainability is the question.

HAO generates stronger free cash flow (-2M), providing more financial flexibility.

Bottom Line

NBIS scores higher overall (47/100 vs 39/100), backed by strong 19.2% margins and 501.0% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited Class A Ordinary Shares

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is an innovative leader in the health technology sector, dedicated to transforming healthcare delivery through cutting-edge solutions. By leveraging advanced technologies such as artificial intelligence and data analytics, the company enhances diagnostic accuracy, treatment efficiency, and overall patient management. With a strong commitment to research and development, Haoxi is strategically positioned to harness emerging trends in healthcare technology, offering substantial growth potential for institutional investors seeking to capitalize on the evolving landscape.

Nebius Group N.V.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Nebius Group N.V. (Ticker: NBIS) is a forward-looking technology company specializing in advanced digital solutions designed to enhance client engagement and streamline operational efficiency across diverse sectors. By harnessing the power of cloud computing, artificial intelligence, and data analytics, Nebius equips businesses to effectively manage the complexities of the digital age. With a strong portfolio of intellectual property and meaningful strategic partnerships, the company is poised to capture significant growth opportunities in the dynamic technology landscape, positioning itself as an appealing investment choice for institutional investors seeking high-growth prospects in tech-driven markets.

Visit Website →

Want to dig deeper into these stocks?